01 November 2005
Apoptosis in liver diseases - detection and therapeutic applications.Saeid Ghavami, Saeid Ghavami, Mohammad Hashemi, Kamran Kadkhoda, Seyed Moayed Alavian, Graham H Bay, Marek Los
Med Sci Monit 2005; 11(11): RA337-345 :: ID: 430372
The liver is continuously exposed to a large antigenic load that includespathogens, toxins, tumor cells and dietary antigens. Amongst the hepatitis viruses, only hepatitis Bvirus (HBV) and hepatitis C virus (HCV) cause chronic hepatitis, which can progress to cirrhosis andhepatocellular carcinoma. Of the different antiviral defense systems employed by the tissue, apoptosissignificantly contributes to the prevention of viral replication, dissemination, and persistence. Lossof tolerance to the liver autoantigens may result in autoimmune hepatitis (AIH). This review outlinesthe recent findings that highlight the role and mechanisms of apoptotic processes in the course of liverdiseases. Among factors that contribute to liver pathology, we discuss the role of tumor necrosis factor(TNF)-alpha, HBx, ds-PKR, TRAIL, FasL, and IL-1alpha. Since TNF and FasL-induced hepatocyte apoptosisis implicated in a wide range of liver diseases, including viral hepatitis, alcoholic hepatitis, ischemia/reperfusionliver injury, and fulminant hepatic failure, these items will be discussed in greater detail in thisreview. We also highlight some recent discoveries that pave the way for the development of new therapeuticstrategies by protecting hepatocytes (for example by employing Bcl-2, Bcl-X(L) or A1/Bfl-1, IAPs, orsynthetic caspase inhibitors), or by the induction of apoptosis in stellate cells. The assessment ofthe severity of liver disease, as well as monitoring of patients with chronic liver disease, remainsa major challenge in clinical hepatology practice. Therefore, a separate chapter is devoted to a novelcytochrome c - based method useful for the diagnosis and monitoring of fulminant hepatitis.
Keywords: Biological Markers - analysis, Autoimmune Diseases - metabolism, Cytochromes c - analysis, Liver Diseases - therapy, Tumor Necrosis Factors - physiology
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
08 Jun 2023 : Clinical ResearchRisk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...
Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical ResearchA Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical ResearchBurden of COVID-19 on Mental Health of Resident Doctors in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical ResearchRisk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...
Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952